申请人:Gilead Sciences, Inc.
公开号:US20210171499A1
公开(公告)日:2021-06-10
The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition in a human.